Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shenzhen Shenxin Biotechnology Co., Ltd

Clinical trials sponsored by Shenzhen Shenxin Biotechnology Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New mRNA vaccine takes aim at RSV in early human trial Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 2 Not yet finished but already full! 2 Completed 1

New mRNA shingles shot shows promise in early trial

Vaccine Completed

This early-stage study tested a new mRNA vaccine called IN001 for preventing shingles in 150 healthy adults aged 50 to 69. The main goals were to check the vaccine's safety, side effects, and how well it triggers the immune system. Researchers gave different doses to find the bes…

Phase 1 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: Vaccine

Last updated Jun 27, 2026 12:02 UTC